Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating an update to the page's revision metadata.SummaryDifference0.0%

- Check10 days agoChange DetectedA line noting '2019 ( U.S. NIH Grant/Contract )' was added to the study's funding/identifiers section. This indicates NIH support for the study in 2019.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's revision number updated from v3.6.4 to v3.6.5, indicating a minor site update that does not alter study details or content. No user-facing data or navigation is affected.SummaryDifference0.0%

- Check31 days agoChange DetectedRemoved the Plain Language Results Summary, sponsor attribution (Sanofi), and the Helpful Links section. This alters the page’s accessibility and navigational context by removing high-level explanations and branding cues.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, reflecting a new build of the site template. This deployment note helps track changes to the page rendering without altering the study content.SummaryDifference0.0%

- Check60 days agoChange Detected- The Publications section now lists the post hoc analysis by Stander et al. with full publication details (Dermatol Ther (Heidelb). 2026 Jun;16(6):2829-2835) and replaces the previous 'Online ahead of print' entry dated Apr 1, 2026.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.